HnRNP U enhances caspase-9 splicing and is modulated by AKT-dependent phosphorylation of hnRNP L

Journal of Biological Chemistry

Volumn 288, Issue 12, 2013, Pages 8575-8584

  Vu, Ngoc T ^a,b   Park, Margaret A ^a   Shultz, Jacqueline C ^a   Goehe, Rachel W ^a   Hoeferlin, L Alexis ^a   Shultz, Michael D ^a   Smith, Sarah A ^e   Lynch, Kristen W ^e   Chalfant, Charles E ^a,c,d  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b Vietnam Education Foundation   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOWN-REGULATION; PHOSPHOINOSITIDES; PRE-MRNA; SPLICE VARIANTS;

PHOSPHORYLATION; RNA;

URANIUM;

CASPASE 9; CIS ACTING ELEMENT; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN L; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN U; MESSENGER RNA PRECURSOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ALTERNATIVE RNA SPLICING; ARTICLE; BINDING SITE; CONTROLLED STUDY; DOWN REGULATION; EXON; GENE CASSETTE; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

ALTERNATIVE SPLICING; BASE SEQUENCE; BINDING SITES; CASPASE 9; CELL LINE, TUMOR; EXONS; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN L; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN U; HUMANS; ISOENZYMES; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-AKT; RNA PRECURSORS; RNA SPLICING; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 84875428613     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.443333     Document Type: Article

References (24)

1. Elmore, S. (2007) Apoptosis. A review of programmed cell death. Toxicol. Pathol. 35, 495-516 (Pubitemid 46911891)
2. Seol, D.-W., and Billiar, T. R. (1999) A caspase-9 variant missing the catalytic site is an endogenous inhibitor of apoptosis. J. Biol. Chem. 274, 2072-2076
3. Srinivasula, S. M., Ahmad, M., Guo, Y., Zhan, Y., Lazebnik, Y., Fernandes- Alnemri, T., and Alnemri, E. S. (1999) Identification of an endogenous dominant-negative short isoform of caspase-9 that can regulate apoptosis. Cancer Res. 59, 999-1002 (Pubitemid 29135957)
4. Goehe, R. W., Shultz, J. C., Murudkar, C., Usanovic, S., Lamour, N. F., Massey, D. H., Zhang, L., Camidge, D. R., Shay, J. W., Minna, J. D., and Chalfant, C. E. (2010) hnRNP L regulates the tumorigenic capacity of lung cancer xenografts in mice via caspase-9 pre-mRNA processing. J. Clin. Invest. 120, 3923-3939
5. Shultz, J. C., Goehe, R. W., Wijesinghe, D. S., Murudkar, C., Hawkins, A. J., Shay, J. W., Minna, J. D., and Chalfant, C. E. (2010) Alternative splicing of caspase-9 is modulated by the phosphoinositide 3-kinase/Akt pathway via phosphorylation of SRp30a. Cancer Res. 70, 9185-9196
6. Chalfant, C. E., Rathman, K., Pinkerman, R. L., Wood, R. E., Obeid, L. M., Ogretmen, B., and Hannun, Y. A. (2002) De novo ceramide regulates the alternative splicing of caspase-9 and Bcl-x in A549 lung adenocarcinoma cells. Dependence on protein phosphatase-1. J. Biol. Chem. 277, 12587-12595 (Pubitemid 34952617)
7. Massiello, A., and Chalfant, C. E. (2006) SRp30a (ASF/SF2) regulates the alternative splicing of caspase-9 pre-mRNA and is required for ceramideresponsiveness. J. Lipid Res. 47, 892-897 (Pubitemid 43764686)
8. Shultz, J. C., Goehe, R. W., Murudkar, C. S., Wijesinghe, D. S., Mayton, E. K., Massiello, A., Hawkins, A. J., Mukerjee, P., Pinkerman, R. L., Park, M. A., and Chalfant, C. E. (2011) SRSF1 regulates the alternative splicing of caspase-9 via a novel intronic splicing enhancer affecting the chemotherapeutic sensitivity of non-small cell lung cancer cells. Mol. Cancer Res. 9, 889-900
9. Kiledjian, M., and Dreyfuss, G. (1992) Primary structure and binding activity of the hnRNP U protein. Binding RNA through RGG box. EMBO J. 11, 2655-2664
10. Fackelmayer, F. O., Dahm, K., Renz, A., Ramsperger, U., and Richter, A. (1994) Nucleic-acid-binding properties of hnRNP-U/SAF-A, a nuclearmatrix protein which binds DNA and RNA in vivo and in vitro. Eur. J. Biochem. 221, 749-757
11. Eggert, M., Michel, J., Schneider, S., Bornfleth, H., Baniahmad, A., Fackelmayer, F. O., Schmidt, S., and Renkawitz, R. (1997) The glucocorticoid receptor is associated with the RNA-binding nuclear matrix protein hnRNP U. J. Biol. Chem. 272, 28471-28478 (Pubitemid 27517795)
12. Kim, M. K., and Nikodem, V. M. (1999) hnRNP U inhibits carboxy-terminal domain phosphorylation by TFIIH and represses RNA polymerase II elongation. Mol. Cell Biol. 19, 6833-6844 (Pubitemid 29441867)
13. Kukalev, A., Nord, Y., Palmberg, C., Bergman, T., and Percipalle, P. (2005) Actin and hnRNP U cooperate for productive transcription by RNA polymerase II. Nat. Struct. Mol. Biol. 12, 238-244 (Pubitemid 43079365)
14. Obrdlik, A., Kukalev, A., Louvet, E., Farrants, A. K., Caputo, L., and Percipalle, P. (2008) The histone acetyltransferase PCAF associates with actin and hnRNP U for RNA polymerase II transcription. Mol. Cell Biol. 28, 6342-6357
15. Yugami, M., Kabe, Y., Yamaguchi, Y., Wada, T., and Handa, H. (2007) hnRNP-U enhances the expression of specific genes by stabilizing mRNA. FEBS Lett. 581, 1-7 (Pubitemid 44960272)
16. Hasegawa, Y., Brockdorff, N., Kawano, S., Tsutui, K., Tsutui, K., and Nakagawa, S. (2010) The matrix protein hnRNP U is required for chromosomal localization of Xist RNA. Dev. Cell 19, 469-476
17. Helbig, R., and Fackelmayer, F. O. (2003) Scaffold attachment factor A (SAF-A) is concentrated in inactive X chromosome territories through its RGG domain. Chromosoma 112, 173-182 (Pubitemid 38063151)
18. Fu, D., and Collins, K. (2007) Purification of human telomerase complexes identifies factors involved in telomerase biogenesis and telomere length regulation. Mol. Cell 28, 773-785 (Pubitemid 350217053)
19. Xiao, R., Tang, P., Yang, B., Huang, J., Zhou, Y., Shao, C., Li, H., Sun, H., Zhang, Y., and Fu, X. D. (2012) Nuclear matrix factor hnRNP U/SAF-A exerts a global control of alternative splicing by regulating U2 snRNP maturation. Mol. Cell 45, 656-668
20. Berglund, F. M., and Clarke, P. R. (2009) hnRNP-U is a specific DNA-dependent protein kinase substrate phosphorylated in response to DNA double-strand breaks. Biochem. Biophys. Res. Commun. 381, 59-64
21. Motta-Mena, L. B., Heyd, F., and Lynch, K. W. (2010) Context-dependent regulatory mechanism of the splicing factor hnRNP L. Mol. Cell 37, 223-234
22. Britton, S., Froment, C., Frit, P., Monsarrat, B., Salles, B., and Calsou, P. (2009) Cell nonhomologous end joining capacity controls SAF-A phosphorylation by DNA-PK in response toDNAdouble-strand breaks inducers. Cell Cycle 8, 3717-3722
23. Matunis, M. J., Michael, W. M., and Dreyfuss, G. (1992) Characterization and primary structure of the poly(C)-binding heterogeneous nuclear ribonucleoprotein complex K protein. Mol. Cell. Biol. 12, 164-171
24. Molina, J. R., Yang, P., Cassivi, S. D., Schild, S. E., and Adjei A. (2008) Non-small cell lung cancer. Epidemiology, risk factors, treatment and survivorship. Mayo Clin. Proc. 83, 584-594 (Pubitemid 351720831)